Antidepressant response in major depressive disorder: a meta-regression comparison of randomized controlled trials and observational studies (Q33936735)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Antidepressant response in major depressive disorder: a meta-regression comparison of randomized controlled trials and observational studies	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

0 references

Antidepressant response in major depressive disorder: a meta-regression comparison of randomized controlled trials and observational studies (English)

1 reference

Europe PubMed Central

30 July 2017

meta-regression

1 reference

based on heuristic

inferred from title

major depressive disorder

1 reference

based on heuristic

inferred from title

Bruno Falissard

3

object named as

Bruno Falissard

0 references

author name string

Florian Naudet

1

1 reference

Europe PubMed Central

30 July 2017

Anne Solène Maria

2

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

8 June 2011

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

6

1 reference

Europe PubMed Central

30 July 2017

e20811

1 reference

Europe PubMed Central

30 July 2017

6

1 reference

Europe PubMed Central

30 July 2017

Antidepressant drug effects and depression severity: a patient-level meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Accelerating response to antidepressant treatment in depression: a review and clinical suggestions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Benefits and risks of drug treatments: how to combine the best evidence on benefits with the best data about adverse effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Performing meta-analysis with incomplete statistical information in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Observational versus experimental studies: what's the evidence for a hierarchy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

A reevaluation of the exclusion criteria used in antidepressant efficacy trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Uses and abuses of meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

The ethics of placebo-controlled trials--a middle ground

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

A comparison of placebo responders and nonresponders in subgroups of depressive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Standardized regression coefficients: a further critique and review of some alternatives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Placebo response in studies of major depression: variable, substantial, and growing

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020811

21 January 2018

Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: meta-analysis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020811

21 January 2018

Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020811

21 January 2018

Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020811

21 January 2018

Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020811

21 January 2018

Effectiveness of long-term psychodynamic psychotherapy: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020811

21 January 2018

Observational versus randomised trial evidence

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020811

21 January 2018

Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020811

21 January 2018

Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020811

21 January 2018

How should meta-regression analyses be undertaken and interpreted?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020811

21 January 2018

The fallacy of employing standardized regression coefficients and correlations as measures of effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

29 October 2018

When are observational studies as credible as randomised trials?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21687681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Some observations on observational research

1 reference

https://pubmed.ncbi.nlm.nih.gov/21687681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relative effectiveness assessment of listed drugs (REAL): a new method for an early comparison of the effectiveness of approved health technologies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21687681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assuring That Double-Blind Is Blind

1 reference

https://pubmed.ncbi.nlm.nih.gov/21687681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0020811

1 reference

Europe PubMed Central

30 July 2017

2011PLoSO...620811N

0 references

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33936735&oldid=1730919213"